← Back to Search

Neural Prosthesis

Neural Enabled Prosthesis for Upper Limb Amputation

N/A
Recruiting
Led By Ranu Jung, Ph.D.
Research Sponsored by Ranu Jung PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 104 weeks - post-treatment
Awards & highlights

Study Summary

This trial will test a new kind of prosthetic hand that uses a neural interface.

Who is the study for?
This trial is for U.S. residents aged 18 or older who have had a unilateral left arm and hand amputation at least 9 months ago, can use a myoelectric arm, and have a functional opposite hand. Participants must be able to travel to the research site, not have limb loss from birth defects, no severe infections or chronic pain, not pregnant/nursing, and without cognitive impairments that affect compliance.Check my eligibility
What is being tested?
The study tests the Adaptive Neural Systems Neural-Enabled Prosthetic Hand (ANS-NEPH) system's feasibility for individuals with an upper limb amputation. It aims to see how well participants can control this advanced prosthesis which uses neural inputs.See study design
What are the potential side effects?
While specific side effects are not listed for this device trial, potential risks may include skin irritation from prosthetic materials, discomfort during use of the prosthesis, possible strain on remaining muscles and joints due to new usage patterns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 104 weeks - post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 104 weeks - post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety of the Neural Stimulation System
Secondary outcome measures
Clinical Assessment: Adaptive Neural Systems - Phantom Limb Telescoping Assessment (ANS-PLTA)
Clinical Assessment: The Southampton Hand Assessment Procedure (SHAP)
Clinical Surveys: 12-Item Short Form Survey (SF-12)
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neural Enabled ProsthesisExperimental Treatment1 Intervention
Neural Enabled Prosthesis Treatment Group

Find a Location

Who is running the clinical trial?

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,778 Total Patients Enrolled
1 Trials studying Prosthesis User
16 Patients Enrolled for Prosthesis User
United States Department of DefenseFED
861 Previous Clinical Trials
227,188 Total Patients Enrolled
4 Trials studying Prosthesis User
334 Patients Enrolled for Prosthesis User
Ranu Jung PhDLead Sponsor

Media Library

Neural Enabled Prosthesis (Neural Prosthesis) Clinical Trial Eligibility Overview. Trial Name: NCT03432325 — N/A
Prosthesis User Research Study Groups: Neural Enabled Prosthesis
Prosthesis User Clinical Trial 2023: Neural Enabled Prosthesis Highlights & Side Effects. Trial Name: NCT03432325 — N/A
Neural Enabled Prosthesis (Neural Prosthesis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03432325 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this trial still in progress?

"Affirmative. The details available on clinicaltrials.gov demonstrate that this medical trial is currently recruiting participants, having first been listed on December 14th 2017 and last modified on July 14th 2022. In total, 6 patients are to be enrolled across 2 sites."

Answered by AI

To what extent is the population being surveyed in this research study?

"Affirmative. Clinicaltrials.gov documents indicate that this study, which was first posted on December 14th 2017 is actively seeking participants for enrollment. A total of 6 patients are needed from 2 medical centres."

Answered by AI
~1 spots leftby Apr 2025